Predicting cancer drivers: are we there yet?

Genome Med. 2012 Nov 26;4(11):88. doi: 10.1186/gm389. eCollection 2012.

Abstract

Genomic variants with a key role in causing cancer or affecting the response to cancer therapeutics need to be identified so that they can be targeted for therapy. The transFIC tool aims to identify somatic point mutations that drive cancer in sequencing projects. This package is available as a web service, a stand-alone program and a website. It improves the functional prediction scores generated by popular established prediction tools and will be useful to cancer researchers.

See research article: http://genomemedicine.com/content/4/11/89.